The Online Investor
Stock Splits
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow Stock Splits

By The Online Investor Staff, updated Sun., Mar. 26, 2:56 PM

Slide #5. Fibrocell Science, Inc. (NASDAQ:FCSC) 1 for 3 Reverse Split

Announced: 3/10/2017
Stock Split: 1 for 3
Record Date: 3/10/2017
Pay Date: 3/13/2017
FCSC Optionable?: Yes

Fibrocell Science is an autologous cell and gene therapy company focused on discovering and developing therapies for the treatment of diseases affecting the skin, connective tissue and joints. Co.'s approach to personalized biologics is distinctive based on its proprietary autologous fibroblast technology: targeting the underlying cause of disease by using cells from the skin to create localized therapies-with or without genetic modification-that are compatible with the unique biology of each patient. Co.'s programs consist of azficel-T for Vocal Cord Scarring, FCX-007 for recessive dystrophic epidermolysis bullosa, FCX-013 for Linear Scleroderma and New Gene Therapy Program for Arthritis.
FCSC Detailed Information Page & Split History »

Company Name:  Fibrocell Science Inc
Website:  www.fibrocellscience.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding FCSC:  2
Total Market Value Held by ETFs:  $41667
Total Market Capitalization:  $29.00M
% of Market Cap. Held by ETFs:  0.14%

Open the FCSC Page at The Online Investor (in a new window) »

March 26, 2017    2:56 PM Eastern
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
84th percentile
(ranked higher than approx. 84% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits | www.TheOnlineInvestor.com | Copyright © 1998 - 2017, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.